Antiplatelet agents in the treatment of thrombotic complications of primary thrombocythemia.
作者信息
Vera J C
出版信息
Can Med Assoc J. 1979 Jan 6;120(1):60-1.
Abstract
摘要
相似文献
1
Antiplatelet agents in the treatment of thrombotic complications of primary thrombocythemia.抗血小板药物在原发性血小板增多症血栓并发症治疗中的应用
Can Med Assoc J. 1979 Jan 6;120(1):60-1.
2
Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin.原发性血小板增多症患者的血小板介导的血栓形成并发症：阿司匹林、血小板减少可逆转，而华法林则不能。
Blood Cells Mol Dis. 2006 Mar-Apr;36(2):199-205. doi: 10.1016/j.bcmd.2005.12.021. Epub 2006 Feb 28.
3
Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.原发性血小板增多症和真性红细胞增多症患者中血小板介导的红斑性肢痛症、脑、眼及冠状动脉微血管缺血和血栓形成表现：一种独特的阿司匹林反应性和华法林抵抗性动脉血栓形成倾向。
Platelets. 2006 Dec;17(8):528-44. doi: 10.1080/09537100600758677.
4
Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.临床和实验室特征、血小板介导的血栓形成和出血并发症的病理生物学，以及原发性血小板增多症和真性红细胞增多症的分子病因：治疗意义。
Semin Thromb Hemost. 2006 Apr;32(3):174-207. doi: 10.1055/s-2006-939431.
5
[Vascular complications of essential thrombocythemia].[原发性血小板增多症的血管并发症]
Bull Acad Natl Med. 2007 Mar;191(3):519-30; discussion 530-3.
6
[Antiplatelet therapy of thrombosis].[血栓形成的抗血小板治疗]
Nihon Rinsho. 1986 May;44(5):1094-103.
7
[Treatment of thrombosis in hemorrhagic thrombocythemia].[出血性血小板增多症中血栓形成的治疗]
Probl Gematol Pereliv Krovi. 1965 Aug;10(8):3-8.
8
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.真性红细胞增多症和原发性血小板增多症患者的复发性血栓形成：发病率、危险因素及治疗效果。
Haematologica. 2008 Mar;93(3):372-80. doi: 10.3324/haematol.12053. Epub 2008 Feb 11.
9
Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention.真性红细胞增多症和原发性血小板增多症中的血栓形成与出血：发病机制与预防
Best Pract Res Clin Haematol. 2006;19(3):617-33. doi: 10.1016/j.beha.2005.07.011.
10
Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with essential thrombocythemia.306例原发性血小板增多症患者血栓形成和/或出血并发症预测风险因素分析
Hematol Oncol. 2007 Sep;25(3):115-20. doi: 10.1002/hon.816.
本文引用的文献
1
Hemorrhagic thrombocythemia.出血性血小板增多症
Am J Gastroenterol. 1962 Dec;38:659-61.
2
Haemorrhagic thrombocythaemia and its treatment with radioactive phosphorus.出血性血小板增多症及其放射性磷治疗
Q J Med. 1962 Apr;31:207-20.
3
Hemorrhagic thrombocythemia: a critical review.出血性血小板增多症：一篇批判性综述。
Blood. 1960 May;15:706-23.
4
Primary thrombocythemia. Clinical, hematological and chromosomal studies of 13 patients.原发性血小板增多症。13例患者的临床、血液学及染色体研究
Helv Med Acta. 1969 May;35(1):20-9.
5
6
7
Essential thrombocythaemia and peripheral gangrene.原发性血小板增多症与外周坏疽
Br Med J. 1974 Aug 31;3(5930):548-52. doi: 10.1136/bmj.3.5930.548.
8
Aspirin and recurrent painful toes and fingers in thrombocythaemia.阿司匹林与血小板增多症中的复发性脚趾和手指疼痛
Lancet. 1972 Feb 19;1(7747):432. doi: 10.1016/s0140-6736(72)90877-x.
9
Microvascular occlusive lesions in primary thrombocythaemia.原发性血小板增多症中的微血管闭塞性病变。
Br J Haematol. 1977 Aug;36(4):553-64. doi: 10.1111/j.1365-2141.1977.tb00996.x.
Zotero 插件